These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31713975)

  • 1. Neuromuscular blockade management for intraoperative neural monitoring.
    Lu IC; Wu SH; Wu CW
    Kaohsiung J Med Sci; 2020 Apr; 36(4):230-235. PubMed ID: 31713975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of rocuronium-induced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve.
    Lu IC; Wu CW; Chang PY; Chen HY; Tseng KY; Randolph GW; Cheng KI; Chiang FY
    Laryngoscope; 2016 Apr; 126(4):1014-9. PubMed ID: 26748952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Neuromuscular Block Management for Neural Monitoring During Thyroid Surgery.
    Lu IC; Wu SH; Chang PY; Ho PY; Huang TY; Lin YC; Kamani D; Randolph GW; Dionigi G; Chiang FY; Wu CW
    J Invest Surg; 2021 Dec; 34(12):1389-1396. PubMed ID: 32791867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between cisatracurium and rocuronium-induced neuromuscular block on laryngeal electromyography recovery after neostigmine reversal in a porcine model.
    Lu IC; Tan H; Wu SH; Huang TY; Tseng HY; Wang JJ; Dionigi G; Chai YJ; Chiang FY; Chang PY; Wu CW
    Front Endocrinol (Lausanne); 2022; 13():875597. PubMed ID: 36004347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intraoperative neuromonitoring on efficacy and safety using sugammadex in thyroid surgery: randomized clinical trial.
    Gunes ME; Dural AC; Akarsu C; Guzey D; Sahbaz NA; Tulubas EK; Bulut S; Donmez T
    Ann Surg Treat Res; 2019 Dec; 97(6):282-290. PubMed ID: 31824882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of intraoperative neuromonitoring during thyroid surgery after administration of nondepolarizing neuromuscular blocking agents.
    Chu KS; Wu SH; Lu IC; Tsai CJ; Wu CW; Kuo WR; Lee KW; Chiang FY
    World J Surg; 2009 Jul; 33(7):1408-13. PubMed ID: 19430831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of potential neuropharmacological activity of neostigmine-glycopyrrolate for intraoperative neural monitoring in thyroid surgery.
    Oh MY; Lee JM; Won D; Huang TY; Wu CW; Dionigi G; Kim HY; Seo M; Choi HS; Chai YJ
    Kaohsiung J Med Sci; 2022 Jan; 38(1):59-64. PubMed ID: 34562340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of the development of antagonists for neuromuscular blocking agents.
    Suzuki K; Takazawa T; Saito S
    J Anesth; 2020 Oct; 34(5):723-728. PubMed ID: 32766960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose of Rocuronium During Thyroid Surgery: Effects on Intraoperative Nerve-Monitoring and Intubation.
    Garofalo E; Bruni A; Scalzi G; Curto LS; Rovida S; Brescia V; Gervasi R; Navalesi P; Innaro N; Longhini F
    J Surg Res; 2021 Sep; 265():131-138. PubMed ID: 33940235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between succinylcholine and rocuronium on the recovery profile of the laryngeal muscles during intraoperative neuromonitoring of the recurrent laryngeal nerve: a prospective porcine model.
    Lu IC; Chang PY; Hsu HT; Tseng KY; Wu CW; Lee KW; Ho KY; Chiang FY
    Kaohsiung J Med Sci; 2013 Sep; 29(9):484-7. PubMed ID: 24018151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Surgeon-Centered Neuromuscular Block Protocol Improving Intraoperative Neuromonitoring Outcome of Thyroid Surgery.
    Lu IC; Hsu CD; Chang PY; Wu SH; Huang TY; Lin YC; Ko HY; Dionigi G; Chai YJ; Chiang FY; Kuo YW; Wu CW
    Front Endocrinol (Lausanne); 2022; 13():817476. PubMed ID: 35222277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of intraoperative dosing patterns of neuromuscular blocking agents.
    Palsen S; Wu A; Beutler SS; Gimlich R; Yang HK; Urman RD
    J Clin Monit Comput; 2019 Jun; 33(3):455-462. PubMed ID: 30094585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Laryngeal Nerve Monitoring and Rocuronium: A Selective Sugammadex Reversal Protocol.
    Empis de Vendin O; Schmartz D; Brunaud L; Fuchs-Buder T
    World J Surg; 2017 Sep; 41(9):2298-2303. PubMed ID: 28349321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex: A Review of Neuromuscular Blockade Reversal.
    Keating GM
    Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Intraoperative Neural Monitoring of the Recurrent Laryngeal Nerve in Thyroid Surgery.
    Hsieh CY; Tan H; Huang HF; Huang TY; Wu CW; Chang PY; Lu DV; Lu IC
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex, the first selective relaxant binding agent for neuromuscular block reversal.
    Stair C; Fernandez-Bustamante A
    Drugs Today (Barc); 2012 Jun; 48(6):405-13. PubMed ID: 22745926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.